Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases
Colorectal impairment reversed in a preclinical model of Parkinson’s Disease ATH434 presents a novel mechanism of action for the treatment...
Source: fnarena.com